nodes	percent_of_prediction	percent_of_DWPC	metapath
Vilazodone—HTR1A—stomach cancer	0.859	1	CbGaD
Vilazodone—Gastroenteritis—Floxuridine—stomach cancer	0.00342	0.0338	CcSEcCtD
Vilazodone—Panic attack—Capecitabine—stomach cancer	0.00255	0.0253	CcSEcCtD
Vilazodone—Night sweats—Capecitabine—stomach cancer	0.00176	0.0175	CcSEcCtD
Vilazodone—Nervous system disorder—Floxuridine—stomach cancer	0.00146	0.0145	CcSEcCtD
Vilazodone—Aripiprazole—ADRB1—stomach cancer	0.00135	0.359	CrCbGaD
Vilazodone—Vision blurred—Mitomycin—stomach cancer	0.00135	0.0134	CcSEcCtD
Vilazodone—Decreased appetite—Floxuridine—stomach cancer	0.00129	0.0128	CcSEcCtD
Vilazodone—Feeling abnormal—Floxuridine—stomach cancer	0.00123	0.0121	CcSEcCtD
Vilazodone—Aripiprazole—HTR1A—stomach cancer	0.00121	0.321	CrCbGaD
Vilazodone—Trazodone—HTR1A—stomach cancer	0.0012	0.32	CrCbGaD
Vilazodone—Asthenia—Floxuridine—stomach cancer	0.00107	0.0106	CcSEcCtD
Vilazodone—Ventricular extrasystoles—Capecitabine—stomach cancer	0.00105	0.0104	CcSEcCtD
Vilazodone—Somnolence—Mitomycin—stomach cancer	0.00104	0.0103	CcSEcCtD
Vilazodone—Hyponatraemia—Irinotecan—stomach cancer	0.00104	0.0103	CcSEcCtD
Vilazodone—Diarrhoea—Floxuridine—stomach cancer	0.00102	0.0101	CcSEcCtD
Vilazodone—Decreased appetite—Mitomycin—stomach cancer	0.00102	0.0101	CcSEcCtD
Vilazodone—Fatigue—Mitomycin—stomach cancer	0.00101	0.00997	CcSEcCtD
Vilazodone—Cataract—Capecitabine—stomach cancer	0.001	0.0099	CcSEcCtD
Vilazodone—Feeling abnormal—Mitomycin—stomach cancer	0.000963	0.00953	CcSEcCtD
Vilazodone—Vomiting—Floxuridine—stomach cancer	0.000946	0.00937	CcSEcCtD
Vilazodone—Irritability—Fluorouracil—stomach cancer	0.000943	0.00934	CcSEcCtD
Vilazodone—Nausea—Floxuridine—stomach cancer	0.000884	0.00876	CcSEcCtD
Vilazodone—Dry eye—Capecitabine—stomach cancer	0.000879	0.00871	CcSEcCtD
Vilazodone—Asthenia—Mitomycin—stomach cancer	0.000838	0.0083	CcSEcCtD
Vilazodone—Diarrhoea—Mitomycin—stomach cancer	0.000799	0.00792	CcSEcCtD
Vilazodone—Gastroenteritis—Capecitabine—stomach cancer	0.000779	0.00772	CcSEcCtD
Vilazodone—Dizziness—Mitomycin—stomach cancer	0.000772	0.00765	CcSEcCtD
Vilazodone—Libido decreased—Capecitabine—stomach cancer	0.000745	0.00738	CcSEcCtD
Vilazodone—Vomiting—Mitomycin—stomach cancer	0.000743	0.00736	CcSEcCtD
Vilazodone—Increased appetite—Capecitabine—stomach cancer	0.000735	0.00728	CcSEcCtD
Vilazodone—Ventricular extrasystoles—Epirubicin—stomach cancer	0.000734	0.00727	CcSEcCtD
Vilazodone—Hyponatraemia—Docetaxel—stomach cancer	0.000716	0.0071	CcSEcCtD
Vilazodone—Migraine—Docetaxel—stomach cancer	0.000702	0.00696	CcSEcCtD
Vilazodone—Connective tissue disorder—Irinotecan—stomach cancer	0.000702	0.00695	CcSEcCtD
Vilazodone—Nausea—Mitomycin—stomach cancer	0.000694	0.00687	CcSEcCtD
Vilazodone—Hyponatraemia—Capecitabine—stomach cancer	0.000694	0.00687	CcSEcCtD
Vilazodone—Disturbance in sexual arousal—Capecitabine—stomach cancer	0.000685	0.00679	CcSEcCtD
Vilazodone—Migraine—Capecitabine—stomach cancer	0.00068	0.00673	CcSEcCtD
Vilazodone—Ventricular extrasystoles—Doxorubicin—stomach cancer	0.000679	0.00673	CcSEcCtD
Vilazodone—Cardiac disorder—Irinotecan—stomach cancer	0.000663	0.00656	CcSEcCtD
Vilazodone—Irritability—Capecitabine—stomach cancer	0.000659	0.00653	CcSEcCtD
Vilazodone—Abnormal dreams—Epirubicin—stomach cancer	0.000655	0.00649	CcSEcCtD
Vilazodone—Breast disorder—Docetaxel—stomach cancer	0.000645	0.00639	CcSEcCtD
Vilazodone—Breast disorder—Capecitabine—stomach cancer	0.000624	0.00618	CcSEcCtD
Vilazodone—Flatulence—Irinotecan—stomach cancer	0.000612	0.00607	CcSEcCtD
Vilazodone—Dry eye—Epirubicin—stomach cancer	0.000612	0.00606	CcSEcCtD
Vilazodone—Abnormal dreams—Doxorubicin—stomach cancer	0.000606	0.006	CcSEcCtD
Vilazodone—Dry eye—Doxorubicin—stomach cancer	0.000567	0.00561	CcSEcCtD
Vilazodone—Vision blurred—Fluorouracil—stomach cancer	0.000561	0.00556	CcSEcCtD
Vilazodone—Convulsion—Fluorouracil—stomach cancer	0.000516	0.00511	CcSEcCtD
Vilazodone—Increased appetite—Epirubicin—stomach cancer	0.000512	0.00507	CcSEcCtD
Vilazodone—Nervous system disorder—Irinotecan—stomach cancer	0.000497	0.00493	CcSEcCtD
Vilazodone—Irritability—Methotrexate—stomach cancer	0.000491	0.00486	CcSEcCtD
Vilazodone—Hyperhidrosis—Irinotecan—stomach cancer	0.00049	0.00486	CcSEcCtD
Vilazodone—Connective tissue disorder—Docetaxel—stomach cancer	0.000485	0.0048	CcSEcCtD
Vilazodone—Hyponatraemia—Epirubicin—stomach cancer	0.000483	0.00479	CcSEcCtD
Vilazodone—Nervous system disorder—Fluorouracil—stomach cancer	0.000476	0.00472	CcSEcCtD
Vilazodone—Increased appetite—Doxorubicin—stomach cancer	0.000474	0.00469	CcSEcCtD
Vilazodone—Migraine—Epirubicin—stomach cancer	0.000474	0.00469	CcSEcCtD
Vilazodone—Connective tissue disorder—Capecitabine—stomach cancer	0.00047	0.00465	CcSEcCtD
Vilazodone—Breast disorder—Methotrexate—stomach cancer	0.000465	0.0046	CcSEcCtD
Vilazodone—Eye disorder—Docetaxel—stomach cancer	0.000461	0.00457	CcSEcCtD
Vilazodone—Insomnia—Irinotecan—stomach cancer	0.000459	0.00454	CcSEcCtD
Vilazodone—Cardiac disorder—Docetaxel—stomach cancer	0.000458	0.00454	CcSEcCtD
Vilazodone—Paraesthesia—Irinotecan—stomach cancer	0.000455	0.00451	CcSEcCtD
Vilazodone—Somnolence—Irinotecan—stomach cancer	0.000451	0.00447	CcSEcCtD
Vilazodone—Hyponatraemia—Doxorubicin—stomach cancer	0.000447	0.00443	CcSEcCtD
Vilazodone—Eye disorder—Capecitabine—stomach cancer	0.000447	0.00442	CcSEcCtD
Vilazodone—Dyspepsia—Irinotecan—stomach cancer	0.000447	0.00442	CcSEcCtD
Vilazodone—Cardiac disorder—Capecitabine—stomach cancer	0.000443	0.00439	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000443	0.00438	CcSEcCtD
Vilazodone—Decreased appetite—Irinotecan—stomach cancer	0.000441	0.00437	CcSEcCtD
Vilazodone—Insomnia—Fluorouracil—stomach cancer	0.000439	0.00435	CcSEcCtD
Vilazodone—Migraine—Doxorubicin—stomach cancer	0.000438	0.00434	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000438	0.00434	CcSEcCtD
Vilazodone—Fatigue—Irinotecan—stomach cancer	0.000437	0.00433	CcSEcCtD
Vilazodone—Paraesthesia—Fluorouracil—stomach cancer	0.000436	0.00432	CcSEcCtD
Vilazodone—Breast disorder—Epirubicin—stomach cancer	0.000435	0.00431	CcSEcCtD
Vilazodone—Mental disorder—Docetaxel—stomach cancer	0.000432	0.00428	CcSEcCtD
Vilazodone—Somnolence—Fluorouracil—stomach cancer	0.000432	0.00428	CcSEcCtD
Vilazodone—Malnutrition—Docetaxel—stomach cancer	0.00043	0.00426	CcSEcCtD
Vilazodone—Dyspepsia—Fluorouracil—stomach cancer	0.000428	0.00424	CcSEcCtD
Vilazodone—Decreased appetite—Fluorouracil—stomach cancer	0.000422	0.00418	CcSEcCtD
Vilazodone—Dysgeusia—Docetaxel—stomach cancer	0.000421	0.00417	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000419	0.00415	CcSEcCtD
Vilazodone—Mental disorder—Capecitabine—stomach cancer	0.000419	0.00415	CcSEcCtD
Vilazodone—Feeling abnormal—Irinotecan—stomach cancer	0.000418	0.00414	CcSEcCtD
Vilazodone—Malnutrition—Capecitabine—stomach cancer	0.000416	0.00412	CcSEcCtD
Vilazodone—Flatulence—Capecitabine—stomach cancer	0.00041	0.00406	CcSEcCtD
Vilazodone—Erectile dysfunction—Methotrexate—stomach cancer	0.000409	0.00405	CcSEcCtD
Vilazodone—Dysgeusia—Capecitabine—stomach cancer	0.000407	0.00403	CcSEcCtD
Vilazodone—Breast disorder—Doxorubicin—stomach cancer	0.000402	0.00399	CcSEcCtD
Vilazodone—Feeling abnormal—Fluorouracil—stomach cancer	0.0004	0.00397	CcSEcCtD
Vilazodone—Vision blurred—Capecitabine—stomach cancer	0.000392	0.00388	CcSEcCtD
Vilazodone—Tremor—Capecitabine—stomach cancer	0.00039	0.00386	CcSEcCtD
Vilazodone—Pollakiuria—Epirubicin—stomach cancer	0.000384	0.00381	CcSEcCtD
Vilazodone—Palpitations—Docetaxel—stomach cancer	0.00038	0.00376	CcSEcCtD
Vilazodone—Convulsion—Docetaxel—stomach cancer	0.000372	0.00369	CcSEcCtD
Vilazodone—Palpitations—Capecitabine—stomach cancer	0.000368	0.00364	CcSEcCtD
Vilazodone—Arthralgia—Docetaxel—stomach cancer	0.000366	0.00362	CcSEcCtD
Vilazodone—Asthenia—Irinotecan—stomach cancer	0.000364	0.0036	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000363	0.0036	CcSEcCtD
Vilazodone—Dry mouth—Docetaxel—stomach cancer	0.000358	0.00354	CcSEcCtD
Vilazodone—Pollakiuria—Doxorubicin—stomach cancer	0.000356	0.00352	CcSEcCtD
Vilazodone—Arthralgia—Capecitabine—stomach cancer	0.000354	0.00351	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000352	0.00348	CcSEcCtD
Vilazodone—Diarrhoea—Irinotecan—stomach cancer	0.000347	0.00344	CcSEcCtD
Vilazodone—Dry mouth—Capecitabine—stomach cancer	0.000346	0.00343	CcSEcCtD
Vilazodone—Nervous system disorder—Docetaxel—stomach cancer	0.000344	0.00341	CcSEcCtD
Vilazodone—Skin disorder—Docetaxel—stomach cancer	0.000341	0.00337	CcSEcCtD
Vilazodone—Dizziness—Irinotecan—stomach cancer	0.000335	0.00332	CcSEcCtD
Vilazodone—Nervous system disorder—Capecitabine—stomach cancer	0.000333	0.0033	CcSEcCtD
Vilazodone—Eye disorder—Methotrexate—stomach cancer	0.000332	0.00329	CcSEcCtD
Vilazodone—Diarrhoea—Fluorouracil—stomach cancer	0.000332	0.00329	CcSEcCtD
Vilazodone—Cardiac disorder—Methotrexate—stomach cancer	0.00033	0.00327	CcSEcCtD
Vilazodone—Skin disorder—Capecitabine—stomach cancer	0.00033	0.00327	CcSEcCtD
Vilazodone—Hyperhidrosis—Capecitabine—stomach cancer	0.000328	0.00325	CcSEcCtD
Vilazodone—Connective tissue disorder—Epirubicin—stomach cancer	0.000327	0.00324	CcSEcCtD
Vilazodone—Vomiting—Irinotecan—stomach cancer	0.000323	0.00319	CcSEcCtD
Vilazodone—Dizziness—Fluorouracil—stomach cancer	0.000321	0.00318	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000319	0.00316	CcSEcCtD
Vilazodone—Insomnia—Docetaxel—stomach cancer	0.000317	0.00314	CcSEcCtD
Vilazodone—Paraesthesia—Docetaxel—stomach cancer	0.000315	0.00312	CcSEcCtD
Vilazodone—Somnolence—Docetaxel—stomach cancer	0.000312	0.00309	CcSEcCtD
Vilazodone—Mental disorder—Methotrexate—stomach cancer	0.000312	0.00309	CcSEcCtD
Vilazodone—Eye disorder—Epirubicin—stomach cancer	0.000311	0.00308	CcSEcCtD
Vilazodone—Malnutrition—Methotrexate—stomach cancer	0.00031	0.00307	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000309	0.00306	CcSEcCtD
Vilazodone—Cardiac disorder—Epirubicin—stomach cancer	0.000309	0.00306	CcSEcCtD
Vilazodone—Vomiting—Fluorouracil—stomach cancer	0.000309	0.00306	CcSEcCtD
Vilazodone—Dyspepsia—Docetaxel—stomach cancer	0.000309	0.00306	CcSEcCtD
Vilazodone—Insomnia—Capecitabine—stomach cancer	0.000307	0.00304	CcSEcCtD
Vilazodone—Paraesthesia—Capecitabine—stomach cancer	0.000305	0.00302	CcSEcCtD
Vilazodone—Decreased appetite—Docetaxel—stomach cancer	0.000305	0.00302	CcSEcCtD
Vilazodone—Dysgeusia—Methotrexate—stomach cancer	0.000303	0.003	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000303	0.003	CcSEcCtD
Vilazodone—Connective tissue disorder—Doxorubicin—stomach cancer	0.000303	0.003	CcSEcCtD
Vilazodone—Fatigue—Docetaxel—stomach cancer	0.000302	0.00299	CcSEcCtD
Vilazodone—Nausea—Irinotecan—stomach cancer	0.000301	0.00298	CcSEcCtD
Vilazodone—Dyspepsia—Capecitabine—stomach cancer	0.000299	0.00296	CcSEcCtD
Vilazodone—Decreased appetite—Capecitabine—stomach cancer	0.000295	0.00292	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000293	0.0029	CcSEcCtD
Vilazodone—Fatigue—Capecitabine—stomach cancer	0.000293	0.0029	CcSEcCtD
Vilazodone—Vision blurred—Methotrexate—stomach cancer	0.000292	0.00289	CcSEcCtD
Vilazodone—Mental disorder—Epirubicin—stomach cancer	0.000292	0.00289	CcSEcCtD
Vilazodone—Malnutrition—Epirubicin—stomach cancer	0.00029	0.00287	CcSEcCtD
Vilazodone—Feeling abnormal—Docetaxel—stomach cancer	0.000289	0.00286	CcSEcCtD
Vilazodone—Nausea—Fluorouracil—stomach cancer	0.000289	0.00286	CcSEcCtD
Vilazodone—Eye disorder—Doxorubicin—stomach cancer	0.000288	0.00285	CcSEcCtD
Vilazodone—Cardiac disorder—Doxorubicin—stomach cancer	0.000286	0.00283	CcSEcCtD
Vilazodone—Flatulence—Epirubicin—stomach cancer	0.000286	0.00283	CcSEcCtD
Vilazodone—Dysgeusia—Epirubicin—stomach cancer	0.000284	0.00281	CcSEcCtD
Vilazodone—Nervousness—Epirubicin—stomach cancer	0.000281	0.00279	CcSEcCtD
Vilazodone—Feeling abnormal—Capecitabine—stomach cancer	0.00028	0.00277	CcSEcCtD
Vilazodone—Vision blurred—Epirubicin—stomach cancer	0.000273	0.00271	CcSEcCtD
Vilazodone—Mental disorder—Doxorubicin—stomach cancer	0.00027	0.00267	CcSEcCtD
Vilazodone—Convulsion—Methotrexate—stomach cancer	0.000268	0.00266	CcSEcCtD
Vilazodone—Malnutrition—Doxorubicin—stomach cancer	0.000268	0.00266	CcSEcCtD
Vilazodone—Agitation—Epirubicin—stomach cancer	0.000266	0.00264	CcSEcCtD
Vilazodone—Flatulence—Doxorubicin—stomach cancer	0.000264	0.00262	CcSEcCtD
Vilazodone—Arthralgia—Methotrexate—stomach cancer	0.000264	0.00261	CcSEcCtD
Vilazodone—Dysgeusia—Doxorubicin—stomach cancer	0.000263	0.0026	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000262	0.00259	CcSEcCtD
Vilazodone—Nervousness—Doxorubicin—stomach cancer	0.00026	0.00258	CcSEcCtD
Vilazodone—Palpitations—Epirubicin—stomach cancer	0.000256	0.00254	CcSEcCtD
Vilazodone—Vision blurred—Doxorubicin—stomach cancer	0.000253	0.0025	CcSEcCtD
Vilazodone—Asthenia—Docetaxel—stomach cancer	0.000252	0.00249	CcSEcCtD
Vilazodone—Convulsion—Epirubicin—stomach cancer	0.000251	0.00249	CcSEcCtD
Vilazodone—Nervous system disorder—Methotrexate—stomach cancer	0.000248	0.00245	CcSEcCtD
Vilazodone—Arthralgia—Epirubicin—stomach cancer	0.000247	0.00244	CcSEcCtD
Vilazodone—Agitation—Doxorubicin—stomach cancer	0.000246	0.00244	CcSEcCtD
Vilazodone—Skin disorder—Methotrexate—stomach cancer	0.000245	0.00243	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000245	0.00243	CcSEcCtD
Vilazodone—Hyperhidrosis—Methotrexate—stomach cancer	0.000244	0.00242	CcSEcCtD
Vilazodone—Asthenia—Capecitabine—stomach cancer	0.000244	0.00241	CcSEcCtD
Vilazodone—Dry mouth—Epirubicin—stomach cancer	0.000241	0.00239	CcSEcCtD
Vilazodone—Diarrhoea—Docetaxel—stomach cancer	0.00024	0.00238	CcSEcCtD
Vilazodone—Palpitations—Doxorubicin—stomach cancer	0.000237	0.00235	CcSEcCtD
Vilazodone—Convulsion—Doxorubicin—stomach cancer	0.000232	0.0023	CcSEcCtD
Vilazodone—Diarrhoea—Capecitabine—stomach cancer	0.000232	0.0023	CcSEcCtD
Vilazodone—Nervous system disorder—Epirubicin—stomach cancer	0.000232	0.0023	CcSEcCtD
Vilazodone—Dizziness—Docetaxel—stomach cancer	0.000232	0.0023	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.00023	0.00228	CcSEcCtD
Vilazodone—Skin disorder—Epirubicin—stomach cancer	0.00023	0.00228	CcSEcCtD
Vilazodone—Hyperhidrosis—Epirubicin—stomach cancer	0.000229	0.00226	CcSEcCtD
Vilazodone—Insomnia—Methotrexate—stomach cancer	0.000229	0.00226	CcSEcCtD
Vilazodone—Arthralgia—Doxorubicin—stomach cancer	0.000228	0.00226	CcSEcCtD
Vilazodone—Paraesthesia—Methotrexate—stomach cancer	0.000227	0.00225	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000227	0.00225	CcSEcCtD
Vilazodone—Somnolence—Methotrexate—stomach cancer	0.000225	0.00223	CcSEcCtD
Vilazodone—Dizziness—Capecitabine—stomach cancer	0.000225	0.00222	CcSEcCtD
Vilazodone—Dry mouth—Doxorubicin—stomach cancer	0.000223	0.00221	CcSEcCtD
Vilazodone—Vomiting—Docetaxel—stomach cancer	0.000223	0.00221	CcSEcCtD
Vilazodone—Dyspepsia—Methotrexate—stomach cancer	0.000222	0.0022	CcSEcCtD
Vilazodone—Decreased appetite—Methotrexate—stomach cancer	0.00022	0.00218	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000218	0.00216	CcSEcCtD
Vilazodone—Fatigue—Methotrexate—stomach cancer	0.000218	0.00216	CcSEcCtD
Vilazodone—Vomiting—Capecitabine—stomach cancer	0.000216	0.00214	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000215	0.00213	CcSEcCtD
Vilazodone—Nervous system disorder—Doxorubicin—stomach cancer	0.000215	0.00213	CcSEcCtD
Vilazodone—Insomnia—Epirubicin—stomach cancer	0.000214	0.00212	CcSEcCtD
Vilazodone—Skin disorder—Doxorubicin—stomach cancer	0.000213	0.00211	CcSEcCtD
Vilazodone—Paraesthesia—Epirubicin—stomach cancer	0.000212	0.0021	CcSEcCtD
Vilazodone—Hyperhidrosis—Doxorubicin—stomach cancer	0.000212	0.0021	CcSEcCtD
Vilazodone—Somnolence—Epirubicin—stomach cancer	0.00021	0.00208	CcSEcCtD
Vilazodone—Nausea—Docetaxel—stomach cancer	0.000208	0.00206	CcSEcCtD
Vilazodone—Feeling abnormal—Methotrexate—stomach cancer	0.000208	0.00206	CcSEcCtD
Vilazodone—Dyspepsia—Epirubicin—stomach cancer	0.000208	0.00206	CcSEcCtD
Vilazodone—Decreased appetite—Epirubicin—stomach cancer	0.000206	0.00204	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000204	0.00202	CcSEcCtD
Vilazodone—Fatigue—Epirubicin—stomach cancer	0.000204	0.00202	CcSEcCtD
Vilazodone—Nausea—Capecitabine—stomach cancer	0.000202	0.002	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000199	0.00197	CcSEcCtD
Vilazodone—Insomnia—Doxorubicin—stomach cancer	0.000198	0.00196	CcSEcCtD
Vilazodone—Paraesthesia—Doxorubicin—stomach cancer	0.000197	0.00195	CcSEcCtD
Vilazodone—Feeling abnormal—Epirubicin—stomach cancer	0.000195	0.00193	CcSEcCtD
Vilazodone—Somnolence—Doxorubicin—stomach cancer	0.000195	0.00193	CcSEcCtD
Vilazodone—Dyspepsia—Doxorubicin—stomach cancer	0.000193	0.00191	CcSEcCtD
Vilazodone—Decreased appetite—Doxorubicin—stomach cancer	0.00019	0.00188	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000189	0.00187	CcSEcCtD
Vilazodone—Fatigue—Doxorubicin—stomach cancer	0.000189	0.00187	CcSEcCtD
Vilazodone—Asthenia—Methotrexate—stomach cancer	0.000181	0.0018	CcSEcCtD
Vilazodone—Feeling abnormal—Doxorubicin—stomach cancer	0.00018	0.00179	CcSEcCtD
Vilazodone—Diarrhoea—Methotrexate—stomach cancer	0.000173	0.00171	CcSEcCtD
Vilazodone—Asthenia—Epirubicin—stomach cancer	0.00017	0.00168	CcSEcCtD
Vilazodone—Dizziness—Methotrexate—stomach cancer	0.000167	0.00166	CcSEcCtD
Vilazodone—Diarrhoea—Epirubicin—stomach cancer	0.000162	0.0016	CcSEcCtD
Vilazodone—Vomiting—Methotrexate—stomach cancer	0.000161	0.00159	CcSEcCtD
Vilazodone—Asthenia—Doxorubicin—stomach cancer	0.000157	0.00156	CcSEcCtD
Vilazodone—Dizziness—Epirubicin—stomach cancer	0.000156	0.00155	CcSEcCtD
Vilazodone—Vomiting—Epirubicin—stomach cancer	0.00015	0.00149	CcSEcCtD
Vilazodone—Nausea—Methotrexate—stomach cancer	0.00015	0.00149	CcSEcCtD
Vilazodone—Diarrhoea—Doxorubicin—stomach cancer	0.00015	0.00148	CcSEcCtD
Vilazodone—Dizziness—Doxorubicin—stomach cancer	0.000145	0.00143	CcSEcCtD
Vilazodone—Nausea—Epirubicin—stomach cancer	0.00014	0.00139	CcSEcCtD
Vilazodone—Vomiting—Doxorubicin—stomach cancer	0.000139	0.00138	CcSEcCtD
Vilazodone—Nausea—Doxorubicin—stomach cancer	0.00013	0.00129	CcSEcCtD
Vilazodone—DRD2—Signaling Pathways—PRKAB1—stomach cancer	2.39e-05	0.000662	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PPAP2A—stomach cancer	2.38e-05	0.00066	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—ANXA1—stomach cancer	2.36e-05	0.000656	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FST—stomach cancer	2.34e-05	0.000649	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—ADRB2—stomach cancer	2.33e-05	0.000646	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—RNF43—stomach cancer	2.31e-05	0.00064	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—KISS1—stomach cancer	2.31e-05	0.00064	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	2.29e-05	0.000636	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—ADRB1—stomach cancer	2.29e-05	0.000635	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—HBEGF—stomach cancer	2.29e-05	0.000635	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—RGS2—stomach cancer	2.26e-05	0.000626	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—GAST—stomach cancer	2.26e-05	0.000626	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PPP2R1A—stomach cancer	2.19e-05	0.000608	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GMPR2—stomach cancer	2.15e-05	0.000597	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—GSTP1—stomach cancer	2.15e-05	0.000597	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FGG—stomach cancer	2.14e-05	0.000594	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CA1—stomach cancer	2.12e-05	0.000589	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CKB—stomach cancer	2.12e-05	0.000589	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NDUFA2—stomach cancer	2.12e-05	0.000589	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—FBP1—stomach cancer	2.12e-05	0.000589	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—HMOX1—stomach cancer	2.12e-05	0.000588	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—ADRB2—stomach cancer	2.11e-05	0.000586	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PPP2R1A—stomach cancer	2.07e-05	0.000574	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PRKAA1—stomach cancer	2.06e-05	0.000572	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FST—stomach cancer	2.05e-05	0.00057	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—ADRB2—stomach cancer	2.04e-05	0.000567	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—HBEGF—stomach cancer	2.01e-05	0.000558	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—TP53—stomach cancer	2.01e-05	0.000556	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—TYMS—stomach cancer	2e-05	0.000555	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PLIN2—stomach cancer	2e-05	0.000553	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—RBP4—stomach cancer	1.99e-05	0.000552	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—CXCL8—stomach cancer	1.99e-05	0.000552	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GAST—stomach cancer	1.98e-05	0.00055	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—RGS2—stomach cancer	1.98e-05	0.00055	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—GSTM1—stomach cancer	1.98e-05	0.000548	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SUCLG1—stomach cancer	1.97e-05	0.000546	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—IDH3B—stomach cancer	1.97e-05	0.000546	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CA2—stomach cancer	1.94e-05	0.000538	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NT5E—stomach cancer	1.89e-05	0.000525	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PGAM1—stomach cancer	1.89e-05	0.000525	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FGG—stomach cancer	1.88e-05	0.000521	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—ERCC2—stomach cancer	1.86e-05	0.000515	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—ADRB2—stomach cancer	1.86e-05	0.000515	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—IL6—stomach cancer	1.84e-05	0.000509	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NDUFV1—stomach cancer	1.83e-05	0.000508	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NDUFS1—stomach cancer	1.83e-05	0.000508	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PPP2R1A—stomach cancer	1.82e-05	0.000504	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PRKAA1—stomach cancer	1.81e-05	0.000502	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PLCE1—stomach cancer	1.8e-05	0.000501	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ALDH7A1—stomach cancer	1.8e-05	0.000501	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—RBP4—stomach cancer	1.75e-05	0.000485	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—MTHFR—stomach cancer	1.75e-05	0.000485	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—CXCL8—stomach cancer	1.75e-05	0.000484	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—UMPS—stomach cancer	1.73e-05	0.00048	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HSPB1—stomach cancer	1.71e-05	0.000475	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—AGTR2—stomach cancer	1.71e-05	0.000475	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—F2R—stomach cancer	1.69e-05	0.000469	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—BMP2—stomach cancer	1.69e-05	0.000469	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—AKR1C3—stomach cancer	1.66e-05	0.000462	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PGLS—stomach cancer	1.63e-05	0.000453	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—BLVRB—stomach cancer	1.63e-05	0.000453	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CAV1—stomach cancer	1.61e-05	0.000447	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PDHA1—stomach cancer	1.61e-05	0.000446	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ECHS1—stomach cancer	1.61e-05	0.000446	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—APOA1—stomach cancer	1.61e-05	0.000446	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—PRKCB—stomach cancer	1.6e-05	0.000442	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ANXA1—stomach cancer	1.59e-05	0.000441	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PPAP2A—stomach cancer	1.56e-05	0.000432	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ADRB1—stomach cancer	1.54e-05	0.000427	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—TYMP—stomach cancer	1.51e-05	0.000419	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—FADS1—stomach cancer	1.51e-05	0.000419	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HSPB1—stomach cancer	1.5e-05	0.000417	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—AGTR2—stomach cancer	1.5e-05	0.000417	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—F2R—stomach cancer	1.49e-05	0.000412	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—BMP2—stomach cancer	1.49e-05	0.000412	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—RPS6—stomach cancer	1.47e-05	0.000408	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—AKR1C3—stomach cancer	1.46e-05	0.000405	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PRKCB—stomach cancer	1.45e-05	0.000402	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HTR1A—stomach cancer	1.45e-05	0.000401	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—IL6ST—stomach cancer	1.44e-05	0.0004	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PPARG—stomach cancer	1.42e-05	0.000393	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—SREBF2—stomach cancer	1.42e-05	0.000393	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PRKCB—stomach cancer	1.4e-05	0.000388	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—RORA—stomach cancer	1.4e-05	0.000388	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ANXA1—stomach cancer	1.4e-05	0.000387	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CKB—stomach cancer	1.39e-05	0.000385	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CA1—stomach cancer	1.39e-05	0.000385	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NDUFA2—stomach cancer	1.39e-05	0.000385	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—FBP1—stomach cancer	1.39e-05	0.000385	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ADRB1—stomach cancer	1.35e-05	0.000375	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HBEGF—stomach cancer	1.35e-05	0.000375	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ALDOB—stomach cancer	1.31e-05	0.000364	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PLIN2—stomach cancer	1.3e-05	0.000362	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—RPS6—stomach cancer	1.29e-05	0.000358	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—IL6R—stomach cancer	1.29e-05	0.000357	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—RHOA—stomach cancer	1.28e-05	0.000355	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—ALB—stomach cancer	1.27e-05	0.000353	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PRKCB—stomach cancer	1.27e-05	0.000353	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CA2—stomach cancer	1.27e-05	0.000352	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—IL6ST—stomach cancer	1.27e-05	0.000351	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ADRB2—stomach cancer	1.25e-05	0.000346	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PGAM1—stomach cancer	1.24e-05	0.000343	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NT5E—stomach cancer	1.24e-05	0.000343	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PPP2R1A—stomach cancer	1.22e-05	0.000339	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ALOX5—stomach cancer	1.22e-05	0.000338	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—NOS3—stomach cancer	1.22e-05	0.000338	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—DPYD—stomach cancer	1.2e-05	0.000333	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HBEGF—stomach cancer	1.19e-05	0.000329	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ALDH7A1—stomach cancer	1.18e-05	0.000327	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PLCE1—stomach cancer	1.18e-05	0.000327	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—RHOA—stomach cancer	1.16e-05	0.000322	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—SMAD4—stomach cancer	1.14e-05	0.000315	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—UMPS—stomach cancer	1.13e-05	0.000314	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—IL6R—stomach cancer	1.13e-05	0.000313	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—RHOA—stomach cancer	1.12e-05	0.000312	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—CXCL8—stomach cancer	1.12e-05	0.000312	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PTGS2—stomach cancer	1.11e-05	0.000309	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ADRB2—stomach cancer	1.1e-05	0.000304	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FYN—stomach cancer	1.08e-05	0.000299	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PPP2R1A—stomach cancer	1.07e-05	0.000298	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GSTT1—stomach cancer	1.06e-05	0.000294	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ECHS1—stomach cancer	1.05e-05	0.000292	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PDHA1—stomach cancer	1.05e-05	0.000292	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CYP2A6—stomach cancer	1.05e-05	0.000291	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—RHOA—stomach cancer	1.02e-05	0.000283	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—CXCL8—stomach cancer	1.02e-05	0.000283	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—AKR1C3—stomach cancer	1.02e-05	0.000283	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FGFR2—stomach cancer	1.01e-05	0.000281	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—SMAD4—stomach cancer	9.97e-06	0.000277	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ENO1—stomach cancer	9.94e-06	0.000276	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—TYMP—stomach cancer	9.89e-06	0.000274	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—FADS1—stomach cancer	9.89e-06	0.000274	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—CXCL8—stomach cancer	9.87e-06	0.000274	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FYN—stomach cancer	9.47e-06	0.000263	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IRS2—stomach cancer	9.27e-06	0.000257	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SREBF2—stomach cancer	9.26e-06	0.000257	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—RORA—stomach cancer	9.15e-06	0.000254	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CAV1—stomach cancer	8.99e-06	0.000249	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—APOA1—stomach cancer	8.97e-06	0.000249	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—CXCL8—stomach cancer	8.96e-06	0.000249	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FGFR2—stomach cancer	8.89e-06	0.000247	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CD44—stomach cancer	8.81e-06	0.000244	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ALDOB—stomach cancer	8.57e-06	0.000238	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PRKCB—stomach cancer	8.56e-06	0.000237	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IL6ST—stomach cancer	8.52e-06	0.000236	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—APC—stomach cancer	8.19e-06	0.000227	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IRS2—stomach cancer	8.14e-06	0.000226	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ALOX5—stomach cancer	7.97e-06	0.000221	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CAV1—stomach cancer	7.89e-06	0.000219	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—APOA1—stomach cancer	7.87e-06	0.000218	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—MAPK3—stomach cancer	7.84e-06	0.000218	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—DPYD—stomach cancer	7.84e-06	0.000217	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IL6R—stomach cancer	7.6e-06	0.000211	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PRKCB—stomach cancer	7.51e-06	0.000208	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PPP2R1A—stomach cancer	7.49e-06	0.000208	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IL6ST—stomach cancer	7.48e-06	0.000208	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—MAPK1—stomach cancer	7.46e-06	0.000207	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—EGFR—stomach cancer	7.46e-06	0.000207	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GSTP1—stomach cancer	7.35e-06	0.000204	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—HMOX1—stomach cancer	7.25e-06	0.000201	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—APC—stomach cancer	7.19e-06	0.000199	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—PIK3CA—stomach cancer	7.13e-06	0.000198	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—SERPINE1—stomach cancer	7.12e-06	0.000197	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—KRAS—stomach cancer	7.05e-06	0.000195	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GSTT1—stomach cancer	6.93e-06	0.000192	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—MAPK3—stomach cancer	6.89e-06	0.000191	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—RHOA—stomach cancer	6.87e-06	0.000191	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PIK3CA—stomach cancer	6.86e-06	0.00019	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CYP2A6—stomach cancer	6.85e-06	0.00019	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—TYMS—stomach cancer	6.83e-06	0.00019	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NOS3—stomach cancer	6.8e-06	0.000189	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GSTM1—stomach cancer	6.75e-06	0.000187	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IL6R—stomach cancer	6.68e-06	0.000185	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—AKR1C3—stomach cancer	6.67e-06	0.000185	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—MAPK1—stomach cancer	6.55e-06	0.000182	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—EGFR—stomach cancer	6.55e-06	0.000182	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ENO1—stomach cancer	6.5e-06	0.00018	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PIK3CA—stomach cancer	6.47e-06	0.00018	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ERBB2—stomach cancer	6.36e-06	0.000176	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ERCC2—stomach cancer	6.35e-06	0.000176	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PIK3CA—stomach cancer	6.26e-06	0.000174	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—SERPINE1—stomach cancer	6.25e-06	0.000173	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—KRAS—stomach cancer	6.19e-06	0.000172	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—RHOA—stomach cancer	6.03e-06	0.000167	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CXCL8—stomach cancer	6.03e-06	0.000167	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—HRAS—stomach cancer	5.99e-06	0.000166	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—MTHFR—stomach cancer	5.97e-06	0.000166	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NOS3—stomach cancer	5.97e-06	0.000166	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CDKN1B—stomach cancer	5.89e-06	0.000163	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CD44—stomach cancer	5.76e-06	0.00016	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—IL6—stomach cancer	5.73e-06	0.000159	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PIK3CA—stomach cancer	5.68e-06	0.000158	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CCND1—stomach cancer	5.62e-06	0.000156	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—JUN—stomach cancer	5.61e-06	0.000155	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ERBB2—stomach cancer	5.58e-06	0.000155	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CAV1—stomach cancer	5.51e-06	0.000153	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—APOA1—stomach cancer	5.49e-06	0.000152	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MMP9—stomach cancer	5.45e-06	0.000151	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CDKN1A—stomach cancer	5.43e-06	0.000151	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MAPK8—stomach cancer	5.3e-06	0.000147	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CXCL8—stomach cancer	5.29e-06	0.000147	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—HRAS—stomach cancer	5.26e-06	0.000146	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CDKN1B—stomach cancer	5.17e-06	0.000143	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—IL6—stomach cancer	5.03e-06	0.00014	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CCND1—stomach cancer	4.93e-06	0.000137	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—JUN—stomach cancer	4.92e-06	0.000137	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PPP2R1A—stomach cancer	4.9e-06	0.000136	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—VEGFA—stomach cancer	4.9e-06	0.000136	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—STAT3—stomach cancer	4.85e-06	0.000134	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PPARG—stomach cancer	4.84e-06	0.000134	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GSTP1—stomach cancer	4.81e-06	0.000133	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MMP9—stomach cancer	4.79e-06	0.000133	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CDKN1A—stomach cancer	4.77e-06	0.000132	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—HMOX1—stomach cancer	4.74e-06	0.000131	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MAPK8—stomach cancer	4.66e-06	0.000129	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MAPK3—stomach cancer	4.63e-06	0.000128	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MYC—stomach cancer	4.51e-06	0.000125	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—TYMS—stomach cancer	4.47e-06	0.000124	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GSTM1—stomach cancer	4.42e-06	0.000122	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MAPK1—stomach cancer	4.41e-06	0.000122	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—EGFR—stomach cancer	4.41e-06	0.000122	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ALB—stomach cancer	4.35e-06	0.000121	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—VEGFA—stomach cancer	4.3e-06	0.000119	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—STAT3—stomach cancer	4.26e-06	0.000118	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NOS3—stomach cancer	4.16e-06	0.000115	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—KRAS—stomach cancer	4.16e-06	0.000115	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ERCC2—stomach cancer	4.15e-06	0.000115	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MAPK3—stomach cancer	4.07e-06	0.000113	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MYC—stomach cancer	3.96e-06	0.00011	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—MTHFR—stomach cancer	3.9e-06	0.000108	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MAPK1—stomach cancer	3.87e-06	0.000107	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—EGFR—stomach cancer	3.87e-06	0.000107	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PIK3CA—stomach cancer	3.82e-06	0.000106	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PTGS2—stomach cancer	3.81e-06	0.000106	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TP53—stomach cancer	3.7e-06	0.000103	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—KRAS—stomach cancer	3.66e-06	0.000101	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CAV1—stomach cancer	3.6e-06	9.99e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—APOA1—stomach cancer	3.59e-06	9.96e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HRAS—stomach cancer	3.54e-06	9.82e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IL6—stomach cancer	3.39e-06	9.39e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PIK3CA—stomach cancer	3.36e-06	9.31e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TP53—stomach cancer	3.25e-06	9.01e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PPARG—stomach cancer	3.16e-06	8.78e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HRAS—stomach cancer	3.11e-06	8.62e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IL6—stomach cancer	2.97e-06	8.25e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ALB—stomach cancer	2.85e-06	7.89e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NOS3—stomach cancer	2.72e-06	7.55e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PTGS2—stomach cancer	2.49e-06	6.91e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PIK3CA—stomach cancer	2.34e-06	6.5e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.53e-06	4.25e-05	CbGpPWpGaD
